Related references
Note: Only part of the references are listed.Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer's disease model
Ankit Parikh et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Self-nanomicellizing solid dispersion of edaravone: part I - oral bioavailability improvement
Ankit Parikh et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability
Ankit Parikh et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation
Ankit Parikh et al.
DRUG DELIVERY (2017)
Microparticles Containing Curcumin Solid Dispersion: Stability, Bioavailability and Anti-Inflammatory Activity
C. C. C. Teixeira et al.
AAPS PHARMSCITECH (2016)
New Drugs from Marine Organisms in Alzheimer's Disease
Patrizia Russo et al.
MARINE DRUGS (2016)
Mice with Sort1 deficiency display normal cognition but elevated anxiety-like behavior
Chun-Sheng Ruan et al.
EXPERIMENTAL NEUROLOGY (2016)
Development of a novel oral delivery system of edaravone for enhancing bioavailability
Ankit Parikh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Impaired Dendritic Development and Memory in Sorbs2 Knock-Out Mice
Qiangge Zhang et al.
JOURNAL OF NEUROSCIENCE (2016)
A cannabinoid link between mitochondria and memory
Etienne Hebert-Chatelain et al.
NATURE (2016)
A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6/Tg2576 Mice
Andrea Wolf et al.
PLOS ONE (2016)
p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease
X-Q Yao et al.
MOLECULAR PSYCHIATRY (2015)
Enhanced Bioavailability and Anticancer Effect of Curcumin-Loaded Electrospun Nanofiber: In Vitro and In Vivo Study
Chuan Wang et al.
NANOSCALE RESEARCH LETTERS (2015)
Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells
Sharvil Patil et al.
PHYTOMEDICINE (2015)
Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits
Shu-Sheng Jiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Acute and sub-chronic toxicity studies of honokiol microemulsion
Qianqian Zhang et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2015)
Enhanced Bioavailability and Anticancer Effect of Curcumin-Loaded Electrospun Nanofiber: In Vitro and In Vivo Study
Chuan Wang et al.
NANOSCALE RESEARCH LETTERS (2015)
Curcumin-Loaded Nanoparticles Potently Induce Adult Neurogenesis and Reverse Cognitive Deficits in Alzheimer's Disease Model via Canonical Wnt/beta-Catenin Pathway
Shashi Kant Tiwari et al.
ACS NANO (2014)
Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
Khalid Iqbal et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Acute and sub-chronic oral toxicity profiles of the aqueous extract of Cortex Dictamni in mice and rats
Lili Wang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
L. S. Schneider et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Mechanisms and Effects of Curcumin on Spatial Learning and Memory Improvement in APPswe/PS1dE9 Mice
Pengwen Wang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Effects of (-)epicatechin on the pathology of APP/PS1 transgenic mice
Yue-Qin Zeng et al.
FRONTIERS IN NEUROLOGY (2014)
Acute and sub-chronic (28 days) oral toxicity evaluation of hydroethanolic extract of Bridelia ferruginea Benth root bark in male rodent animals
Batomayena Bakoma et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Modeling Alzheimer's disease: from past to future
Claudia Saraceno et al.
FRONTIERS IN PHARMACOLOGY (2013)
Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease
Patrizia Mecocci et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Anticoagulant activities of curcumin and its derivative
Dong-Chan Kim et al.
BMB REPORTS (2012)
NIA Commentary: Translational Issues in Alzheimer's Disease Drug Development
Neil S. Buckholtz et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Mice fed on a diet enriched with genetically engineered multivitamin corn show no sub-acute toxic effects and no sub-chronic toxicity
Gemma Arjo et al.
PLANT BIOTECHNOLOGY JOURNAL (2012)
Overstimulation of newborn mice leads to behavioral differences and deficits in cognitive performance
D. A. Christakis et al.
SCIENTIFIC REPORTS (2012)
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
John M. Ringman et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Animal Models of Alzheimer Disease
Frank M. LaFerla et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The novel object recognition memory: neurobiology, test procedure, and its modifications
M. Antunes et al.
COGNITIVE PROCESSING (2012)
Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)
F. Mangialasche et al.
LANCET NEUROLOGY (2011)
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche et al.
LANCET NEUROLOGY (2010)
Intramuscular delivery of a single chain antibody gene reduces brain Aβ burden in a mouse model of Alzheimer's disease
Yan-Jiang Wang et al.
NEUROBIOLOGY OF AGING (2009)
Consumption of Grape Seed Extract Prevents Amyloid-beta Deposition and Attenuates Inflammation in Brain of an Alzheimer's Disease Mouse
Yan-Jiang Wang et al.
NEUROTOXICITY RESEARCH (2009)
The effect of curcumin (turmeric) on Alzheimer's disease: An overview
Shrikant Mishra et al.
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2008)
Bioavailability of curcumin: Problems and promises
Preetha Anand et al.
MOLECULAR PHARMACEUTICS (2007)
100 years and counting: Prospects for defeating Alzheimer's disease
Erik D. Roberson et al.
SCIENCE (2006)
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Charles V. Vorhees et al.
NATURE PROTOCOLS (2006)
A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?
PT Francis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes
GW Arendash et al.
BRAIN RESEARCH (2001)
Share Paper
